Dulera 200/5 mcg

Description

Dulera 200/5 mcg Inhaler
(Mometasone Furoate 200 mcg / Formoterol Fumarate 5 mcg)

Description:
Dulera 200/5 mcg Inhaler is a combination inhaler that combines mometasone furoate (200 mcg), a corticosteroid, and formoterol fumarate (5 mcg), a long-acting beta-agonist (LABA), to provide long-term management of asthma and chronic obstructive pulmonary disease (COPD) in adults and adolescents aged 12 years and older. This inhaler is designed for twice-daily use, offering symptom control and preventing bronchoconstriction and airway inflammation associated with these respiratory conditions.

The mometasone furoate works by reducing airway inflammation, while formoterol fumarate helps to relax the muscles around the airways, opening them up for better airflow. Dulera 200/5 mcg is specifically intended for maintenance therapy, not for immediate relief of acute asthma or COPD symptoms.

Key Features:

• Dual-Action Formula: Contains 200 mcg mometasone furoate, a potent corticosteroid to reduce inflammation, and 5 mcg formoterol fumarate, a long-acting bronchodilator that helps to open the airways for sustained relief.
• Twice-Daily Dosing: Designed for morning and evening use, Dulera provides 24-hour asthma control, reducing symptoms and preventing exacerbations in both asthma and COPD patients.
• Convenient Metered-Dose Inhaler: The Dulera inhaler delivers a fine mist of medication for easy inhalation and precise dosing with each actuation, providing accurate delivery to the lungs.